Background. -Ranking of hospitals by lay media has attracted widespread attention but may not accurately reflect quality. Acute myocardial infarction (AMI) mortality is a straightforward measure of clinical outcome frequently used by ranking algorithms. Aims. -Our aim was to assess whether ranking among top hospitals correlated with lower in-hospital risk-adjusted mortality following admission for AMI. Methods. -Using a hierarchical regression model and the comprehensive nationwide database of hospital AMI admissions from 2004 to 2007 in France, we analysed crude and risk-adjusted hospital mortality rates in the ranked ('best') hospitals versus non-ranked hospitals. We subsequently restricted the comparison to non-ranked hospitals with matching on-site facilities.
Background
Public reporting of hospital performance is a current policy used by several governmental entities to compare hospital-specific or physician-specific outcomes. California [1] , Pennsylvania [2] , Scotland [3] and Ontario, Canada [4] , for example, have released hospital-specific reports for mortality following admission for acute myocardial infarction (AMI). While the regulatory and financing institutions promote the use of access measures and disseminate accreditation reports, the lay press has developed an annual hospital 'star rating' system that has gained wide public acceptance.
In France, as well as in other countries, the criteria used in lay press ranking differ from those used for institutional public reporting. The yearly ranking by 'Le Point' magazine is the most widely circulated comparison of hospitals in France. Le Point ranks the 50 'best' hospitals by speciality; the rank of hospitals that are not among the top 50 is not disclosed further. The sales volume of the annual edition of Le Point on hospital ranking has always been the highest, except for presidential election editions. This success probably stems from the simplicity of the onedimensional measure in the ranking system, contrary to the multidimensional and narrative assessments published by academic and governmental institutions. Additionally, the Le Point ranking is performed by condition, on a limited number of conditions or procedures (e.g. AMI, hip or knee replacement, cataract surgery and prostate cancer). Results are presented as a list of 'the best hospitals for AMI care' followed by another list of 'the best hospitals for hip replacement'.
Our objective was to assess the robustness of this ranking. We selected AMI for the following reasons: while patients who have an AMI in France are referred via the emergency ambulance service and do not usually have the choice of a hospital and therefore would not use the magazine ranking, AMI care is a proxy for cardiac care in general. In the USA, top-ranked hospitals for AMI were found to provide evidence-based care for both acute and non-acute coronary syndromes and more generally to deliver care of better quality. We examined whether being ranked in the top 50 hospitals for care of AMI on the Le Point list was associated with lower risk-adjusted in-hospital mortality [5] .
Methods
Using the comprehensive French nationwide hospital database, we examined crude and adjusted hospital mortality following admission for AMI among the 50 top-ranked hospitals on the Le Point hospital rating list and compared it with non-ranked French hospitals treating at least 10 AMI patients per year. We also performed a reverse analysis using the Le Point criteria to assess how well they predicted hospital mortality in the total AMI population.
Data source
The French medical information systems programme (PMSI) files for years [2004] [2005] [2006] [2007] were used as the data source for this retrospective analysis. The PMSI file is an administrative database maintained by the Ministry of Health, containing all reimbursement claims submitted by acute-care hospitals (public, private not-for-profit and private for-profit, both teaching and non-teaching). The database records the following information: patient age, sex, date of admission, date of discharge, primary diagnosis, up to eight secondary diagnoses, up to six procedures, discharge status and total charges. Linkage of multiple admissions is possible. Out-ofhospital mortality, drugs on discharge and quality of life measures are not available. We also used information on the hospitals' structures and equipment via the Annual Statistics of Health Institutions database maintained by the Ministry of Health (statistique annuelle des établissements de santé [SAE] ).
Study population Hospitals
The population in this study consisted of all French public, private not-for-profit and private for-profit hospitals with at least 10 discharges (each year) for an AMI, defined by a principal diagnosis code of I21-I22 of the International Classification of Diseases, Tenth Revision (ICD-10) during the years 2004-2007. Records were linked for transfers. The first step of the selection process was to exclude hospitals for which data on status were missing or incomplete; due to statistical analysis constraints (see below), the second step excluded hospitals with fewer than 10 yearly discharges for AMI. The comparison was repeated after restricting the analysis to hospitals with similar levels of technical equipment as those found in the top-ranked hospitals. Results of the selection process are presented in the flowchart in Appendix 1, together with a description of hospitals and discharges excluded [6] .
We extracted for each hospital: size (number of beds) and activity (number of yearly admissions for I21-I22 ICD-10 diagnoses); equipment available to treat cardiology patients (i.e. cardiac care unit, cardiac surgery and catheterization laboratory); teaching and ownership status.
Star rating system (Le Point rating)
The ranking methodology developed by Le Point magazine is available online [7] . In short, the rank is a composite of case volume, notoriety, specialization, percentage of outpatient procedures, short length of stay, technical equipment and rate of hospital-acquired infections. The weight given to each item and the aggregation method are not disclosed. Only the top 50 ranked hospitals are listed and ranks for the non-listed hospitals are not disclosed: hospitals are therefore characterized by a dichotomous variable (ranked versus not ranked) instead of a continuous rank. As far as treatment of acute coronary syndromes was concerned, the list of ranked hospitals remained stable over our study period.
Patients
Admissions in the database were linked to obtain patientlevel data. The primary purpose of the multilevel logit model was to predict the probability of in-hospital mortality during an admission for AMI, after controlling for patient and hospital characteristics. The following risk adjustments used a hierarchical modelling approach: age, sex, secondary diagnoses, previous AMI, tachycardia, congestive heart failure and renal failure [8] (Appendix 2).
Statistical analysis
A multilevel analysis was performed to estimate the expected probability of in-hospital mortality and identify the determinants of mortality. This approach was justified by the hierarchical structure of the data comprising two levels of analysis: the hospital level and the discharge/patientlevel. Hierarchical models take into account both the variability between discharges and the variability between hospitals and avoid inappropriate conclusions related to residual variability when a source of variability is ignored [9] . This method also allowed determination of the variability attributable to each level [10] .
In order to obtain unbiased and accurate estimations using this type of model, a sufficient sample size at both the hospital and the patient/discharge levels is required, with one being dependent on the size of the other. In the absence of consensus regarding appropriate sample size, we followed recommendations from the literature [11, 12] in selecting hospitals with at least 10 yearly discharges on average to ensure a sample with at least 40 individuals per group.
A multilevel logit model was adopted because of the dichotomous nature of the dependent variable analysed (deceased versus alive). The model was used to identify a significant difference between hospitals with respect to mortality rates and to determine the patient and hospital characteristics associated with an increased probability of mortality. We subsequently compared the average in-hospital mortality rates of ranked hospitals versus nonranked hospitals, first without adjustment and then after adjusting for age, sex and comorbid conditions. We then restricted the comparison to hospitals that were equipped with matching technical facilities.
We built a multilevel model to predict mortality based on the Le Point criteria applied to all hospitals and patients. Only the following variables were used (other variables such as 'notoriety' being unavailable to the public): cardiac care unit, cardiac surgery, catheterization lab, annual AMI discharges and percentage of angioplasty. We used backward selection because of correlation between the variables of interest.
Univariate differences were tested using the Wilcoxon signed-rank test. The comparison was repeated, focusing on the non-ranked hospitals presenting the same structural characteristics as the top-ranked hospitals (i.e. general and multidisciplinary hospitals equipped with at least one of three facilities: cardiac surgery, catheterization laboratory or cardiac care unit). Multilevel analysis was performed with HLM software (Scientific Software International, Lincolnwood, IL, USA). All other analyses were performed with 
Results
The study sample consisted of 192,372 patients treated in 439 hospitals over the 4-year period. Hospital and patient characteristics are presented in Tables 1 and 2 . Top-ranked hospitals were almost exclusively university hospitals with on-site revascularization facilities, admitting on average 400 AMIs each year. Compared with other hospitals, they admitted more AMIs (Fig. 1) and their patients were younger, more frequently men, presented fewer comorbidities and were more likely to be treated with percutaneous coronary intervention (PCI). The average length of stay (2004-2007) was 6.9 ± 1.8 days for all patients, 7.0 ± 1.9 days for patients in non-ranked hospitals and 6.7 ± 1.2 days for patients in ranked hospitals.
Analysis of mortality data
The average in-hospital mortality rate over the 4-year period was 8.85%, decreasing from 13.8% in 2004 to 9.4% in 2006 and 8.1% in 2007. There was a large variation in-hospital mortality rates between hospitals, ranging from 0.02% to 33%. Over 90% of the hospitals had a mortality rate below 20%, while 26 hospitals had a mortality rate above 20% (Fig. 2) . 
Results of the multilevel model

Results of the empty model
The empty model did not contain any explanatory variables and estimated the proportion of variation in mortality at the hospital level. The intercept was −2.05 and the variance component of the random effect was 0.37, significantly different from 0 (P < 0.001), indicating the existence of mortality differences related to hospitals. The model estimated that hospital variations accounted for approximately 10% of the total unexplained variance, which means that the existing mortality variations were explained by differences between hospitals (intraclass correlation = 0.101).
Results of the multilevel patient/discharge model
The patient variables positively associated with mortality were age (with a relative 6% increase in mortality risk every year), female sex (associated with a 4% increase in mortality, independent of age), recurrent AMI (associated with a 42% increase in mortality) and an earlier year of admission. Higher AMI volume was associated with risk reduction, with odds ratios ranging from 0.82 for yearly case volume superior to 100 to 0.77 for yearly case volume superior to 250 (P = 0.002). Adjustment for age and sex (step 1) and comorbidities (step 2) reduced the mortality difference between hospitals. After adjustment for age and sex, over 90% of the hospitals had a mortality rate below 10%, while 26 hospitals (6%) had a mortality rate above 10% ( Fig. 2 and Tables 3 and 4) .
Mortality in ranked versus non-ranked hospitals
Of the 50 top-ranked hospitals for cardiac care, 43 were part of our database, totalling 64,916 patients. The seven missing hospitals were either part of a hospital consortium that did not release individual institution's characteristics (n = 2) or were excluded because of missing structure and equipment data (n = 5 In-hospital mortality (Fig. 3) was lower in ranked versus non-ranked hospitals (7.5% vs. 11.9%; P < 0.001). The survival advantage associated with admission to top-ranked hospitals Figure 2 . Mortality rate by hospital, estimated from the hierarchical model: entire population of acute myocardial infarction discharges, crude mortality, age/sex-adjusted mortality and age/sex/comorbidity-adjusted mortality (n = 192,372 discharges and 439 hospitals).
was reduced by adjustment for age and sex (5.7% vs. 6.4%; P = 0.087) and comorbidities (4.9% vs. 5.5%; P = 0.102).
We restricted the comparison to the 168 similarly equipped hospitals with matching on-site facilities for revascularization and the corresponding 125,896 patients. Similarly equipped hospitals admitted on average 122 ± 99 AMIs yearly (vs. 377 ± 125 in ranked hospitals), their patient population was older than in ranked hospitals (69.5 ± 15 vs. 66.1 ± 15 years) and their average length of stay was 7.1 ± 1.5 days. Compared with similarly equipped hospitals, ranked hospitals performed more revascularizations (PCI or coronary artery bypass graft): 56.6% vs. 33.8% patients. Crude unadjusted in-hospital mortality was lower in ranked hospitals than in similarly equipped hospitals (7.5% vs. 10.9%; P < 0.001) (Fig. 4) . Adjustment for age, sex and comorbidities reduced the mortality advantage: 5.4% vs. 6.0% (P = 0.063) and 4.6% vs. 5.2% (P = 0.078) (Fig. 5) . When revascularization was added to the adjustment, the mortality difference was reversed, with a higher mortality in ranked versus non-ranked hospitals (9.5% vs. 8.1%; P = 0.0033).
Mortality in ranked hospitals
Additionally, comparison of the level of adjusted mortality within ranked hospitals (Fig. 6) showed that there was no relation between this and the level of a hospital rank in the Le Point rating (kappa = 0.0 between hospital ranks and their adjusted mortality ranks).
Use of the Le Point criteria to predict mortality
Among all explicit variables in the Le Point ranking, the percentage of angioplasty had the greatest protective effect (odds ratio 0.23; P < 0.001), followed by the presence of a cardiac care unit (odds ratio 0.87; P = 0.004). The other variables did not predict mortality in the full dataset.
Discussion
Our analysis of AMI in-hospital mortality in 439 hospitals and 192,372 AMI admissions found that top-ranked hospitals have similar adjusted AMI mortality rates to those not ranked and that hospital differences account for a small fraction of the variations. Differences between hospitals accounted for 10% of the differences in mortality. A substantial portion of the survival advantage of patients admitted to top-ranked hospitals was explained by demographics and comorbidities as well as higher use of revascularization. In other words, there was no evidence that patients who had an AMI increased their likelihood of survival if they chose a star-rated hospital rather than any hospital admitting over 100 patients with AMI per year and equipped with the appropriate facilities. Our data are consistent with prior observations on the importance of case volume and on the role of on-site revascularization facilities [5, 13, 14] . Other authors found similar limitations in the rankings produced by the United States News and World Report or consumer-orientated websites [5, [15] [16] [17] [18] . In their 2006 study of 'Hospital Compare' ratings, Werner and Bradlow reported that '[a]cross all performance measures for heart attack, the difference between the topand bottom-rated hospitals was 0.5% for inpatient mortality, 0.6% for 30-day mortality and 1.2% for 1-year mortality. The difference in 30-day mortality rates for top-rated hospitals for all heart attack measures versus bottom-rated hospitals for all measures was 1.1%' [19] . There is, nevertheless, evidence pointing in the opposite direction, with a relationship between AMI mortality and hospital quality; in that case, however, quality of care was assessed by disease-specific indicators instead of global hospital scores and reporting was not entrusted to the lay press.
Study limitations
Technical limitations of our study result from the administrative dataset itself. Full adjustment for confounders is limited by the fact that the French national discharge database does not currently provide reliable information on comorbid conditions to allow full risk adjustment as recommended by other authors, nor does it provide information on non-interventional treatments received or AMI severity at admission [20] . The poor quality of coding for comorbid conditions has been reported previously [21] . In the CRUSADE study, investigators noted that 'nearly two-thirds of patient medical records did not discuss comorbid diseases (such as diabetes mellitus, hypertension or smoking) despite the prevalence of these conditions in the treated population' [22] . This coding issue explains the difficulties encountered by risk adjustment models, although its real power to explain the variability in mortality could be challenged [23] . At this stage, we are unable to disentangle what pertains to hospital quality from what pertains to patient severity in a decision to undertake PCI. The hospital coding system did not differentiate PCI from primary PCI, which was found to be an important predictor of mortality [14] .
Another limitation was the exclusion of hospitals with missing data and hospitals with fewer than 10 AMI discharges per year. Gale et al. [6] showed that a high proportion of missing data is associated with worse 30-day mortality rates and that missing data affected the calculation of standardized mortality rates. Missing hospital data in our dataset did not concern any of the top-ranked hospitals nor the similarly equipped hospitals. The exclusion of very-lowvolume hospitals was both a technical decision, because multilevel modelling does not provide valid estimates without a minimum set of observations, and a political decision on our part because these hospitals are not meant to treat AMI.
A final limitation was the indicator itself: supposing that it could be made to reflect accurately hospital differences, it remains a 'simplistic' index that does not account for many important aspects of quality of care and may not be the appropriate gold standard to judge the quality of a ranking system. We chose mortality because of the current political focus on (adjusted) mortality rates [13, 24] . The French Minister of Health was requested in 2010 by the President to ensure reporting of in-hospital mortality, thus following the lead of England, the USA, Canada, the Netherlands and Sweden, despite the ongoing controversy regarding the use of in-hospital mortality to monitor quality [25] .
Conclusions
There is public demand for hospital rankings, as evidenced by the overwhelming success of the published rankings and their spread across most news magazines in France and elsewhere in the world. Despite evidence of the risk of misclassification and its potential negative consequences for hospitals or physicians, news magazines appear determined to pursue such rankings. This abundance can be viewed as a welcome endeavour to increase transparency and respond to patients' requests [26, 27] but it can also create confusion among patients [15, 28] when, as shown in our example, objective indicators and ranking do not coincide.
In the end, while hospital rankings in the lay press are likely to persist because of public demand, provision by academic institutions of information on how good these indicators are in predicting outcomes that matter and innovative methods to assess performance (Gale BMC) should ensure that hospital ratings are consistent with improvement inhospital quality.
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